| SS/JrHsdMcwi |
resting tone of middle cerebral artery |
controlled losartan content drinking water (20 mg/kg/d) (for 7 days) then controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63.0 days-98.0 days |
7 |
[(Dmax - Drest) /Dmax] x 100 |
38.0 |
% |
2.1 |
5.56 |
ex vivo videomicroscopy |
0.0 |
|
69569 |
732 |
| SS/JrHsdMcwi |
resting tone of middle cerebral artery |
controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63.0 days-98.0 days |
9 |
[(Dmax - Drest) /Dmax] x 100 |
42.0 |
% |
3.3 |
9.9 |
ex vivo videomicroscopy |
0.0 |
|
67246 |
732 |
| SS/JrHsdMcwi |
resting tone of middle cerebral artery |
0.9% sodium chloride solution (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63.0 days-98.0 days |
6 |
[(Dmax - Drest) /Dmax] x 100 |
38.0 |
% |
2.1 |
5.14 |
ex vivo videomicroscopy |
0.0 |
|
69572 |
732 |
| SS/JrHsdMcwi |
resting tone of middle cerebral artery |
controlled tempol content drinking water (15 mg/kg/d) (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63.0 days-98.0 days |
5 |
[(Dmax - Drest) /Dmax] x 100 |
48.0 |
% |
1.9 |
4.25 |
ex vivo videomicroscopy |
0.0 |
|
69584 |
732 |
| SS/JrHsdMcwi |
resting tone of middle cerebral artery |
controlled tempol content drinking water (15 mg/kg/d) (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) then NG-nitroarginine methyl ester (100 umol/l) (for 0.3 hours) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63.0 days-98.0 days |
6 |
[(Dmax - Drest) /Dmax] x 100 |
44.0 |
% |
3.3 |
8.08 |
ex vivo videomicroscopy |
0.0 |
|
69587 |
732 |
| SS/JrHsdMcwi |
resting tone of middle cerebral artery |
angiotensin II (3 ng/kg/min) (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63.0 days-98.0 days |
5 |
[(Dmax - Drest) /Dmax] x 100 |
37.0 |
% |
1.5 |
3.35 |
ex vivo videomicroscopy |
0.0 |
|
69575 |
732 |
| SS/JrHsdMcwi |
resting tone of middle cerebral artery |
controlled captopril content drinking water (100 mg/kg/d) (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63.0 days-98.0 days |
6 |
[(Dmax - Drest) /Dmax] x 100 |
41.0 |
% |
3.3 |
8.08 |
ex vivo videomicroscopy |
0.0 |
|
69563 |
732 |
| SS/JrHsdMcwi |
resting tone of middle cerebral artery |
angiotensin II (3 ng/kg/min) (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) then NG-nitroarginine methyl ester (100 umol/l) (for 0.3 hours) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63.0 days-98.0 days |
5 |
[(Dmax - Drest) /Dmax] x 100 |
54.0 |
% |
2.2 |
4.92 |
ex vivo videomicroscopy |
0.0 |
|
69578 |
732 |